Loading…

The role of miRNA-377 as a tumor suppressor in lung cancer by negative regulation of genes belonging to ErbB signaling pathway

Background The ErbB signaling pathway plays important role in the pathogenesis of lung cancer. We explored the role of miRNA-377 as a tumor suppressor in NSCLC through silencing of some genes in the ErbB pathway. Methods and Results The targeting effect of miRNA-377 on EGFR, MAPK1, ABL2, and PAK2 wa...

Full description

Saved in:
Bibliographic Details
Published in:Molecular biology reports 2022, Vol.49 (1), p.85-95
Main Authors: Hashemi, Saba, Yari, Naghmeh, Rahimi Jamnani, Fatemeh, Mahdian, Reza, Karimi, Morteza, Zeinali, Sirous, Rafiee, Mohammad Hesam, Azizi, Masoumeh
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c419t-fb720c2a00758a881af614a88fd3316f8e6659fe78926989c9daa83960f20f823
cites cdi_FETCH-LOGICAL-c419t-fb720c2a00758a881af614a88fd3316f8e6659fe78926989c9daa83960f20f823
container_end_page 95
container_issue 1
container_start_page 85
container_title Molecular biology reports
container_volume 49
creator Hashemi, Saba
Yari, Naghmeh
Rahimi Jamnani, Fatemeh
Mahdian, Reza
Karimi, Morteza
Zeinali, Sirous
Rafiee, Mohammad Hesam
Azizi, Masoumeh
description Background The ErbB signaling pathway plays important role in the pathogenesis of lung cancer. We explored the role of miRNA-377 as a tumor suppressor in NSCLC through silencing of some genes in the ErbB pathway. Methods and Results The targeting effect of miRNA-377 on EGFR, MAPK1, ABL2, and PAK2 was evaluated. The expression levels of these genes and miRNA-377 were surveyed in NSCLC and normal human tissues, Calu-6, and A549 cells. Real-time PCR was used to figure out whether miRNA-377 could decrease the target genes mRNAs in transfected lung cancer cell lines. The effects of miRNA-377 on apoptosis cell and proliferation were analyzed. We showed that miRNA-377 targets EGFR, MAPK1, and PAK2 mRNAs in in-silico and luciferase reporter assay. The expression of miRNA-377 was significantly downregulated in human NSCLC tissues, Calu-6 and A549 cells compared to their controls. We observed a negative correlation between EGFR, MAPK1, PAK2, and miRNA-377 expression in human NSCLC tissues. A significant reduction in EGFR, MAPK1, and PAK2 mRNA levels was detected, following miRNA-377 transfection in Calu-6 and A549 cells. The higher levels of miRNA-377 in Calu-6, and A549 cells induced apoptosis and reduced proliferation, significantly. Conclusions All these data reveal that miRNA-377 functions as a tumor suppressor in NSCLC and may serve as a potential therapeutic target for the treatment of NSCLC.
doi_str_mv 10.1007/s11033-021-06844-6
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2584018141</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2618382186</sourcerecordid><originalsourceid>FETCH-LOGICAL-c419t-fb720c2a00758a881af614a88fd3316f8e6659fe78926989c9daa83960f20f823</originalsourceid><addsrcrecordid>eNp9kUFv1DAQhS1ERZfCH-CALHHhYvDYjuMcS9UWpIpKVTlbTnacpkrsYCdFe-G34-0WkDhw8pPne88ePULeAP8AnNcfMwCXknEBjGujFNPPyAaqWjLV1OY52XDJgSlTwTF5mfM951xBXb0gx1JpbYDDhvy8vUOa4og0ejoNN19Pmaxr6jJ1dFmnmGhe5zlhzkUOgY5r6GnnQoeJtjsasHfL8FAisF_HImPYB_UYMNMWxxj6oRiWSM9T-4nmoQ9u3N_Mbrn74XavyJF3Y8bXT-cJ-XZxfnv2mV1dX345O71inYJmYb6tBe-EK1tXxhkDzmtQRfitlKC9Qa2rxmNtGqEb03TN1jkjG8294N4IeULeH3LnFL-vmBc7DbnDcXQB45qtqIziYEBBQd_9g97HNZVvF0qDkUaA0YUSB6pLMeeE3s5pmFzaWeB23449tGNLO_axHbs3vX2KXtsJt38sv-sogDwAuYxCj-nv2_-J_QUI9Jkb</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2618382186</pqid></control><display><type>article</type><title>The role of miRNA-377 as a tumor suppressor in lung cancer by negative regulation of genes belonging to ErbB signaling pathway</title><source>Springer Link</source><creator>Hashemi, Saba ; Yari, Naghmeh ; Rahimi Jamnani, Fatemeh ; Mahdian, Reza ; Karimi, Morteza ; Zeinali, Sirous ; Rafiee, Mohammad Hesam ; Azizi, Masoumeh</creator><creatorcontrib>Hashemi, Saba ; Yari, Naghmeh ; Rahimi Jamnani, Fatemeh ; Mahdian, Reza ; Karimi, Morteza ; Zeinali, Sirous ; Rafiee, Mohammad Hesam ; Azizi, Masoumeh</creatorcontrib><description>Background The ErbB signaling pathway plays important role in the pathogenesis of lung cancer. We explored the role of miRNA-377 as a tumor suppressor in NSCLC through silencing of some genes in the ErbB pathway. Methods and Results The targeting effect of miRNA-377 on EGFR, MAPK1, ABL2, and PAK2 was evaluated. The expression levels of these genes and miRNA-377 were surveyed in NSCLC and normal human tissues, Calu-6, and A549 cells. Real-time PCR was used to figure out whether miRNA-377 could decrease the target genes mRNAs in transfected lung cancer cell lines. The effects of miRNA-377 on apoptosis cell and proliferation were analyzed. We showed that miRNA-377 targets EGFR, MAPK1, and PAK2 mRNAs in in-silico and luciferase reporter assay. The expression of miRNA-377 was significantly downregulated in human NSCLC tissues, Calu-6 and A549 cells compared to their controls. We observed a negative correlation between EGFR, MAPK1, PAK2, and miRNA-377 expression in human NSCLC tissues. A significant reduction in EGFR, MAPK1, and PAK2 mRNA levels was detected, following miRNA-377 transfection in Calu-6 and A549 cells. The higher levels of miRNA-377 in Calu-6, and A549 cells induced apoptosis and reduced proliferation, significantly. Conclusions All these data reveal that miRNA-377 functions as a tumor suppressor in NSCLC and may serve as a potential therapeutic target for the treatment of NSCLC.</description><identifier>ISSN: 0301-4851</identifier><identifier>EISSN: 1573-4978</identifier><identifier>DOI: 10.1007/s11033-021-06844-6</identifier><identifier>PMID: 34668101</identifier><language>eng</language><publisher>Dordrecht: Springer Netherlands</publisher><subject>3' Untranslated Regions ; A549 Cells ; Animal Anatomy ; Animal Biochemistry ; Apoptosis ; Biomedical and Life Sciences ; Carcinoma, Non-Small-Cell Lung - genetics ; Cell Line, Tumor ; Cell Movement ; Cell Proliferation ; Cell Survival ; Down-Regulation ; Epidermal growth factor receptors ; ErbB protein ; ErbB Receptors - genetics ; Gene Expression Regulation, Neoplastic ; Gene regulation ; Gene silencing ; Histology ; Humans ; Life Sciences ; Lung cancer ; Lung Neoplasms - genetics ; MicroRNAs - genetics ; miRNA ; Mitogen-Activated Protein Kinase 1 - genetics ; Morphology ; mRNA ; Non-small cell lung carcinoma ; Original Article ; p21-Activated Kinases - genetics ; Signal Transduction ; Therapeutic targets ; Transfection ; Tumor cell lines ; Tumor suppressor genes ; Tumors</subject><ispartof>Molecular biology reports, 2022, Vol.49 (1), p.85-95</ispartof><rights>The Author(s), under exclusive licence to Springer Nature B.V. 2021</rights><rights>2021. The Author(s), under exclusive licence to Springer Nature B.V.</rights><rights>The Author(s), under exclusive licence to Springer Nature B.V. 2021.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c419t-fb720c2a00758a881af614a88fd3316f8e6659fe78926989c9daa83960f20f823</citedby><cites>FETCH-LOGICAL-c419t-fb720c2a00758a881af614a88fd3316f8e6659fe78926989c9daa83960f20f823</cites><orcidid>0000-0003-4679-3248</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34668101$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hashemi, Saba</creatorcontrib><creatorcontrib>Yari, Naghmeh</creatorcontrib><creatorcontrib>Rahimi Jamnani, Fatemeh</creatorcontrib><creatorcontrib>Mahdian, Reza</creatorcontrib><creatorcontrib>Karimi, Morteza</creatorcontrib><creatorcontrib>Zeinali, Sirous</creatorcontrib><creatorcontrib>Rafiee, Mohammad Hesam</creatorcontrib><creatorcontrib>Azizi, Masoumeh</creatorcontrib><title>The role of miRNA-377 as a tumor suppressor in lung cancer by negative regulation of genes belonging to ErbB signaling pathway</title><title>Molecular biology reports</title><addtitle>Mol Biol Rep</addtitle><addtitle>Mol Biol Rep</addtitle><description>Background The ErbB signaling pathway plays important role in the pathogenesis of lung cancer. We explored the role of miRNA-377 as a tumor suppressor in NSCLC through silencing of some genes in the ErbB pathway. Methods and Results The targeting effect of miRNA-377 on EGFR, MAPK1, ABL2, and PAK2 was evaluated. The expression levels of these genes and miRNA-377 were surveyed in NSCLC and normal human tissues, Calu-6, and A549 cells. Real-time PCR was used to figure out whether miRNA-377 could decrease the target genes mRNAs in transfected lung cancer cell lines. The effects of miRNA-377 on apoptosis cell and proliferation were analyzed. We showed that miRNA-377 targets EGFR, MAPK1, and PAK2 mRNAs in in-silico and luciferase reporter assay. The expression of miRNA-377 was significantly downregulated in human NSCLC tissues, Calu-6 and A549 cells compared to their controls. We observed a negative correlation between EGFR, MAPK1, PAK2, and miRNA-377 expression in human NSCLC tissues. A significant reduction in EGFR, MAPK1, and PAK2 mRNA levels was detected, following miRNA-377 transfection in Calu-6 and A549 cells. The higher levels of miRNA-377 in Calu-6, and A549 cells induced apoptosis and reduced proliferation, significantly. Conclusions All these data reveal that miRNA-377 functions as a tumor suppressor in NSCLC and may serve as a potential therapeutic target for the treatment of NSCLC.</description><subject>3' Untranslated Regions</subject><subject>A549 Cells</subject><subject>Animal Anatomy</subject><subject>Animal Biochemistry</subject><subject>Apoptosis</subject><subject>Biomedical and Life Sciences</subject><subject>Carcinoma, Non-Small-Cell Lung - genetics</subject><subject>Cell Line, Tumor</subject><subject>Cell Movement</subject><subject>Cell Proliferation</subject><subject>Cell Survival</subject><subject>Down-Regulation</subject><subject>Epidermal growth factor receptors</subject><subject>ErbB protein</subject><subject>ErbB Receptors - genetics</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Gene regulation</subject><subject>Gene silencing</subject><subject>Histology</subject><subject>Humans</subject><subject>Life Sciences</subject><subject>Lung cancer</subject><subject>Lung Neoplasms - genetics</subject><subject>MicroRNAs - genetics</subject><subject>miRNA</subject><subject>Mitogen-Activated Protein Kinase 1 - genetics</subject><subject>Morphology</subject><subject>mRNA</subject><subject>Non-small cell lung carcinoma</subject><subject>Original Article</subject><subject>p21-Activated Kinases - genetics</subject><subject>Signal Transduction</subject><subject>Therapeutic targets</subject><subject>Transfection</subject><subject>Tumor cell lines</subject><subject>Tumor suppressor genes</subject><subject>Tumors</subject><issn>0301-4851</issn><issn>1573-4978</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kUFv1DAQhS1ERZfCH-CALHHhYvDYjuMcS9UWpIpKVTlbTnacpkrsYCdFe-G34-0WkDhw8pPne88ePULeAP8AnNcfMwCXknEBjGujFNPPyAaqWjLV1OY52XDJgSlTwTF5mfM951xBXb0gx1JpbYDDhvy8vUOa4og0ejoNN19Pmaxr6jJ1dFmnmGhe5zlhzkUOgY5r6GnnQoeJtjsasHfL8FAisF_HImPYB_UYMNMWxxj6oRiWSM9T-4nmoQ9u3N_Mbrn74XavyJF3Y8bXT-cJ-XZxfnv2mV1dX345O71inYJmYb6tBe-EK1tXxhkDzmtQRfitlKC9Qa2rxmNtGqEb03TN1jkjG8294N4IeULeH3LnFL-vmBc7DbnDcXQB45qtqIziYEBBQd_9g97HNZVvF0qDkUaA0YUSB6pLMeeE3s5pmFzaWeB23449tGNLO_axHbs3vX2KXtsJt38sv-sogDwAuYxCj-nv2_-J_QUI9Jkb</recordid><startdate>2022</startdate><enddate>2022</enddate><creator>Hashemi, Saba</creator><creator>Yari, Naghmeh</creator><creator>Rahimi Jamnani, Fatemeh</creator><creator>Mahdian, Reza</creator><creator>Karimi, Morteza</creator><creator>Zeinali, Sirous</creator><creator>Rafiee, Mohammad Hesam</creator><creator>Azizi, Masoumeh</creator><general>Springer Netherlands</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7TM</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>RC3</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-4679-3248</orcidid></search><sort><creationdate>2022</creationdate><title>The role of miRNA-377 as a tumor suppressor in lung cancer by negative regulation of genes belonging to ErbB signaling pathway</title><author>Hashemi, Saba ; Yari, Naghmeh ; Rahimi Jamnani, Fatemeh ; Mahdian, Reza ; Karimi, Morteza ; Zeinali, Sirous ; Rafiee, Mohammad Hesam ; Azizi, Masoumeh</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c419t-fb720c2a00758a881af614a88fd3316f8e6659fe78926989c9daa83960f20f823</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>3' Untranslated Regions</topic><topic>A549 Cells</topic><topic>Animal Anatomy</topic><topic>Animal Biochemistry</topic><topic>Apoptosis</topic><topic>Biomedical and Life Sciences</topic><topic>Carcinoma, Non-Small-Cell Lung - genetics</topic><topic>Cell Line, Tumor</topic><topic>Cell Movement</topic><topic>Cell Proliferation</topic><topic>Cell Survival</topic><topic>Down-Regulation</topic><topic>Epidermal growth factor receptors</topic><topic>ErbB protein</topic><topic>ErbB Receptors - genetics</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Gene regulation</topic><topic>Gene silencing</topic><topic>Histology</topic><topic>Humans</topic><topic>Life Sciences</topic><topic>Lung cancer</topic><topic>Lung Neoplasms - genetics</topic><topic>MicroRNAs - genetics</topic><topic>miRNA</topic><topic>Mitogen-Activated Protein Kinase 1 - genetics</topic><topic>Morphology</topic><topic>mRNA</topic><topic>Non-small cell lung carcinoma</topic><topic>Original Article</topic><topic>p21-Activated Kinases - genetics</topic><topic>Signal Transduction</topic><topic>Therapeutic targets</topic><topic>Transfection</topic><topic>Tumor cell lines</topic><topic>Tumor suppressor genes</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hashemi, Saba</creatorcontrib><creatorcontrib>Yari, Naghmeh</creatorcontrib><creatorcontrib>Rahimi Jamnani, Fatemeh</creatorcontrib><creatorcontrib>Mahdian, Reza</creatorcontrib><creatorcontrib>Karimi, Morteza</creatorcontrib><creatorcontrib>Zeinali, Sirous</creatorcontrib><creatorcontrib>Rafiee, Mohammad Hesam</creatorcontrib><creatorcontrib>Azizi, Masoumeh</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest Science Journals</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Molecular biology reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hashemi, Saba</au><au>Yari, Naghmeh</au><au>Rahimi Jamnani, Fatemeh</au><au>Mahdian, Reza</au><au>Karimi, Morteza</au><au>Zeinali, Sirous</au><au>Rafiee, Mohammad Hesam</au><au>Azizi, Masoumeh</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The role of miRNA-377 as a tumor suppressor in lung cancer by negative regulation of genes belonging to ErbB signaling pathway</atitle><jtitle>Molecular biology reports</jtitle><stitle>Mol Biol Rep</stitle><addtitle>Mol Biol Rep</addtitle><date>2022</date><risdate>2022</risdate><volume>49</volume><issue>1</issue><spage>85</spage><epage>95</epage><pages>85-95</pages><issn>0301-4851</issn><eissn>1573-4978</eissn><abstract>Background The ErbB signaling pathway plays important role in the pathogenesis of lung cancer. We explored the role of miRNA-377 as a tumor suppressor in NSCLC through silencing of some genes in the ErbB pathway. Methods and Results The targeting effect of miRNA-377 on EGFR, MAPK1, ABL2, and PAK2 was evaluated. The expression levels of these genes and miRNA-377 were surveyed in NSCLC and normal human tissues, Calu-6, and A549 cells. Real-time PCR was used to figure out whether miRNA-377 could decrease the target genes mRNAs in transfected lung cancer cell lines. The effects of miRNA-377 on apoptosis cell and proliferation were analyzed. We showed that miRNA-377 targets EGFR, MAPK1, and PAK2 mRNAs in in-silico and luciferase reporter assay. The expression of miRNA-377 was significantly downregulated in human NSCLC tissues, Calu-6 and A549 cells compared to their controls. We observed a negative correlation between EGFR, MAPK1, PAK2, and miRNA-377 expression in human NSCLC tissues. A significant reduction in EGFR, MAPK1, and PAK2 mRNA levels was detected, following miRNA-377 transfection in Calu-6 and A549 cells. The higher levels of miRNA-377 in Calu-6, and A549 cells induced apoptosis and reduced proliferation, significantly. Conclusions All these data reveal that miRNA-377 functions as a tumor suppressor in NSCLC and may serve as a potential therapeutic target for the treatment of NSCLC.</abstract><cop>Dordrecht</cop><pub>Springer Netherlands</pub><pmid>34668101</pmid><doi>10.1007/s11033-021-06844-6</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0003-4679-3248</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0301-4851
ispartof Molecular biology reports, 2022, Vol.49 (1), p.85-95
issn 0301-4851
1573-4978
language eng
recordid cdi_proquest_miscellaneous_2584018141
source Springer Link
subjects 3' Untranslated Regions
A549 Cells
Animal Anatomy
Animal Biochemistry
Apoptosis
Biomedical and Life Sciences
Carcinoma, Non-Small-Cell Lung - genetics
Cell Line, Tumor
Cell Movement
Cell Proliferation
Cell Survival
Down-Regulation
Epidermal growth factor receptors
ErbB protein
ErbB Receptors - genetics
Gene Expression Regulation, Neoplastic
Gene regulation
Gene silencing
Histology
Humans
Life Sciences
Lung cancer
Lung Neoplasms - genetics
MicroRNAs - genetics
miRNA
Mitogen-Activated Protein Kinase 1 - genetics
Morphology
mRNA
Non-small cell lung carcinoma
Original Article
p21-Activated Kinases - genetics
Signal Transduction
Therapeutic targets
Transfection
Tumor cell lines
Tumor suppressor genes
Tumors
title The role of miRNA-377 as a tumor suppressor in lung cancer by negative regulation of genes belonging to ErbB signaling pathway
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T13%3A03%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20role%20of%20miRNA-377%20as%20a%20tumor%20suppressor%20in%20lung%20cancer%20by%20negative%20regulation%20of%20genes%20belonging%20to%20ErbB%20signaling%20pathway&rft.jtitle=Molecular%20biology%20reports&rft.au=Hashemi,%20Saba&rft.date=2022&rft.volume=49&rft.issue=1&rft.spage=85&rft.epage=95&rft.pages=85-95&rft.issn=0301-4851&rft.eissn=1573-4978&rft_id=info:doi/10.1007/s11033-021-06844-6&rft_dat=%3Cproquest_cross%3E2618382186%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c419t-fb720c2a00758a881af614a88fd3316f8e6659fe78926989c9daa83960f20f823%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2618382186&rft_id=info:pmid/34668101&rfr_iscdi=true